|
1
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bao S, Zheng J and Shi G: The role of T
helper 17 cells in the pathogenesis of hepatitis B virus-related
liver cirrhosis (Review). Mol Med Rep. 16:3713–3719. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roeb E: Matrix metalloproteinases and
liver fibrosis (translational aspects). Matrix Biol. 68-69:463–473.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu F, Fan X, Chen B, Dong P and Zheng J:
Activation of hepatic stellate cells is inhibited by
microRNA-378a-3p via Wnt10a. Cell Physiol Biochem. 39:2409–2420.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li T and Cho WC: MicroRNAs: Mechanisms,
functions and progress. Genomics Proteomics Bioinformatics.
10:237–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rottiers V and Naar AM: MicroRNAs in
metabolism and metabolic disorders. Nat Rev Mol Cell Biol.
13:239–250. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sud N, Taher J and Su Q: MicroRNAs and
noncoding RNAs in hepatic lipid and lipoprotein metabolism:
Potential therapeutic targets of metabolic disorders. Drug Dev Res.
76:318–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei S, Wang Q, Zhou H, Qiu J, Li C, Shi C,
Zhou S, Liu R and Lu L: MiR-455-3p alleviates hepatic stellate cell
activation and liver fibrosis by suppressing HSF1 expression. Mol
Ther Nucleic Acids. 16:758–769. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zou Y, Li S, Li Z, Song D, Zhang S and Yao
Q: MiR-146a attenuates liver fibrosis by inhibiting transforming
growth factor-β1 mediated epithelial-mesenchymal transition in
hepatocytes. Cell Signal. 58:1–8. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He Y, Huang C, Zhang SP, Sun X, Long XR
and Li J: The potential of microRNAs in liver fibrosis. Cell
Signal. 24:2268–2272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Noetel A, Kwiecinski M, Elfimova N, Huang
J and Odenthal M: MicroRNA are central players in anti- and
profibrotic gene regulation during liver fibrosis. Front Physiol.
3:492012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun J, Zhang H, Li L, Yu L and Fu L:
MicroRNA-9 limits hepatic fibrosis by suppressing the activation
and proliferation of hepatic stellate cells by directly targeting
MRP1/ABCC1. Oncol Rep. 37:1698–1706. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ju B, Nie Y, Yang X, Wang X, Li F, Wang M,
Wang C and Zhang H: Mir-193a/b-3p relieves hepatic fibrosis and
restrains proliferation and activation of hepatic stellate cells. J
Cell Mol Med. 23:3824–3832. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng J, He X, Zhang L and Liu P:
MicroRNA26a protects vascular smooth muscle cells against
H2O2induced injury through activation of the PTEN/AKT/mTOR pathway.
Int J Mol Med. 42:1367–1378. 2018.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Yao Y, Sun F and Lei M: MiR-25 inhibits
sepsis-induced cardio-myocyte apoptosis by targetting PTEN. Biosci
Rep. 13:382018.
|
|
17
|
Mimche PN, Lee CM, Mimche SM, Thapa M,
Grakoui A, Henkemeyer M and Lamb TJ: EphB2 receptor tyrosine kinase
promotes hepatic fibrogenesis in mice via activation of hepatic
stellate cells. Sci Rep. 8:25322018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma L, Yang X, Wei R, Ye T, Zhou JK, Wen M,
Men R, Li P, Dong B, Liu L, et al: MicroRNA-214 promotes hepatic
stellate cell activation and liver fibrosis by suppressing sufu
expression. Cell Death Dis. 9:7182018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang P, Lei S, Wang X, Xu W, Hu P, Chen F,
Zhang X, Yin C and Xie W: MicroRNA-134 deactivates hepatic stellate
cells by targeting TGF-β activated kinase 1-binding protein 1.
Biochem Cell Biol. 97:505–512. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mormone E, George J and Nieto N: Molecular
pathogenesis of hepatic fibrosis and current therapeutic
approaches. Chem Biol Interact. 193:225–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Zhao R, Wang H, Luo Y, Wang X, Niu
W, Zhou Y, Wen Q, Fan S, Li X, et al: MiR-141 is involved in
BRD7-mediated cell proliferation and tumor formation through
suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.
Cell Death Dis. 7:e21562016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang TJ, Ren JJ, Zhang QQ, Kong YY, Zhang
HY, Guo XH, Fan HQ and Liu LX: IGFBPrP1 accelerates autophagy and
activation of hepatic stellate cells via mutual regulation between
H19 and PI3K/AKT/mTOR pathway. Biomed Pharmacother. 116:1090342019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guerrero-Zotano A, Mayer IA and Arteaga
CL: PI3K/AKT/mTOR: Role in breast cancer progression, drug
resistance, and treatment. Cancer Metastasis Rev. 35:515–524. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bai T, Lian LH, Wu YL, Wan Y and Nan JX:
Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling
pathways in activated hepatic stellate cells. Int Immunopharmacol.
15:275–281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Feng MH, Li JW, Sun HT, He SQ and Pang J:
Sulforaphane inhibits the activation of hepatic stellate cell by
miRNA-423-5p targeting suppressor of fused. Hum Cell. 32:403–410.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang YH, Kuo HC, Yang YL and Wang FS:
MicroRNA-29a is a key regulon that regulates BRD4 and mitigates
liver fibrosis in mice by inhibiting hepatic stellate cell
activation. Int J Med Sci. 16:212–220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tao L, Xue D, Shen D, Ma W, Zhang J, Wang
X, Zhang W, Wu L, Pan K, Yang Y, et al: MicroRNA-942 mediates
hepatic stellate cell activation by regulating BAMBI expression in
human liver fibrosis. Arch Toxicol. 92:2935–2946. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Ji L, Su S, Zhu X, Cheng F, Jia X,
Zhou Q and Zhou Y: Leptin up-regulates microRNA-27a/b-3p level in
hepatic stellate cells. Exp Cell Res. 366:63–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang YZ, Zhang W, Wang YH, Fu XL and Xue
CQ: Repression of liver cirrhosis achieved by inhibitory effect of
miR-454 on hepatic stellate cells activation and proliferation via
wnt10a. J Biochem. 165:361–367. 2019. View Article : Google Scholar
|
|
30
|
Sekiya Y, Ogawa T, Yoshizato K, Ikeda K
and Kawada N: Suppression of hepatic stellate cell activation by
microRNA-29b. Biochem Biophys Res Commun. 412:74–79. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Chu ES, Chen HY, Man K, Go MY,
Huang XR, Lan HY, Sung JJ and Yu J: MicroRNA-29b prevents liver
fibrosis by attenuating hepatic stellate cell activation and
inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget.
6:7325–7338. 2015. View Article : Google Scholar :
|
|
32
|
Ji J, Zhang J, Huang G, Qian J, Wang X and
Mei S: Over-Expressed microRNA-27a and 27b influence fat
accumulation and cell proliferation during rat hepatic stellate
cell activation. FEBS Lett. 583:759–766. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou B and Yu JW: A novel identified
circular RNA, circRNA_010567, promotes myocardial fibrosis via
suppressing miR-141 by targeting TGF-β1. Biochem Biophys Res
Commun. 487:769–775. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li XY, Wang SS, Han Z, Han F, Chang YP,
Yang Y, Xue M, Sun B and Chen LM: Triptolide restores autophagy to
alleviate diabetic renal fibrosis through the
miR-141-3p/PTEN/Akt/mTOR Pathway. Mol Ther Nucleic Acids. 9:48–56.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tan Y, Pan T, Ye Y, Ge G, Chen L, Wen D
and Zou S: Serum microRNAs as potential biomarkers of primary
biliary cirrhosis. PLoS One. 9:e1114242014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hao LS, Zhang XL, An JY, Karlin J, Tian
XP, Dun ZN, Xie SR and Chen S: PTEN expression is down-regulated in
liver tissues of rats with hepatic fibrosis induced by biliary
stenosis. APMIS. 117:681–691. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng L, Chen X, Guo J, Sun H, Liu L, Shih
DQ and Zhang X: Differential expression of PTEN in hepatic tissue
and hepatic stellate cells during rat liver fibrosis and its
reversal. Int J Mol Med. 30:1424–1430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tao H, Zhang JG, Qin RH, Dai C, Shi P,
Yang JJ, Deng ZY and Shi KH: LncRNA GAS5 controls cardiac
fibroblast activation and fibrosis by targeting miR-21 via
PTEN/MMP-2 signaling pathway. Toxicology. 386:11–18. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
McClelland AD, Herman-Edelstein M, Komers
R, Jha JC, Winbanks CE, Hagiwara S, Gregorevic P, Kantharidis P and
Cooper ME: MiR-21 promotes renal fibrosis in diabetic nephropathy
by targeting PTEN and SMAD7. Clin Sci (Lond). 129:1237–1249. 2015.
View Article : Google Scholar
|
|
40
|
Parapuram SK, Shi-wen X, Elliott C, Welch
ID, Jones H, Baron M, Denton CP, Abraham DJ and Leask A: Loss of
PTEN expression by dermal fibroblasts causes skin fibrosis. J
Invest Dermatol. 131:1996–2003. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
He L, Gubbins J, Peng Z, Medina V, Fei F,
Asahina K, Wang J, Kahn M, Rountree CB and Stiles BL: Activation of
hepatic stellate cell in pten null liver injury model. Fibrogenesis
Tissue Repair. 9:82016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Niu X, Fu N, Du J, Wang R, Wang Y, Zhao S,
Du H, Wan B, Zhang Y, Sun D and Nan Y: MiR-1273g-3p modulates
activation and apoptosis of hepatic stellate cells by directly
targeting PTEN in HCV-related liver fibrosis. FEBS Lett.
590:2709–2724. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zheng J, Wu C, Xu Z, Xia P, Dong P, Chen B
and Yu F: Hepatic stellate cell is activated by microRNA-181b via
PTEN/Akt pathway. Mol Cell Biochem. 398:1–9. 2015. View Article : Google Scholar
|
|
44
|
Voloshenyuk TG, Landesman ES, Khoutorova
E, Hart AD and Gardner JD: Induction of cardiac fibroblast lysyl
oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling.
Cytokine. 55:90–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Friedman SL: Molecular regulation of
hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Son G, Hines IN, Lindquist J, Schrum LW
and Rippe RA: Inhibition of phosphatidylinositol 3-kinase signaling
in hepatic stellate cells blocks the progression of hepatic
fibrosis. Hepatology. 50:1512–1523. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Reif S, Lang A, Lindquist JN, Yata Y,
Gabele E, Scanga A, Brenner DA and Rippe RA: The role of focal
adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in
hepatic stellate cell proliferation and type I collagen expression.
J Biol Chem. 278:8083–8090. 2003. View Article : Google Scholar
|
|
48
|
Wu SM, Li TH, Yun H, Ai HW and Zhang KH:
MiR-140-3p knockdown suppresses cell proliferation and fibrogenesis
in hepatic stellate cells via PTEN-Mediated AKT/mTOR signaling.
Yonsei Med J. 60:561–569. 2019. View Article : Google Scholar : PubMed/NCBI
|
